{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,12]],"date-time":"2026-02-12T07:54:37Z","timestamp":1770882877318,"version":"3.50.1"},"reference-count":17,"publisher":"Wiley","issue":"6","license":[{"start":{"date-parts":[[2017,6,1]],"date-time":"2017-06-01T00:00:00Z","timestamp":1496275200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Cathet Cardio Intervent"],"published-print":{"date-parts":[[2017,11,15]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec><jats:title>Objectives<\/jats:title><jats:p>This study sought to investigate whether the percutaneous mitral regurgitation (MR) reduction with the MitraClip\u00ae system in end\u2010stage heart failure patients with a left ventricular ejection fraction (LVEF) of &lt;20% also effects beneficial outcome or whether the underlying myogenic problem is leading and therefore of prognostic relevance.<\/jats:p><\/jats:sec><jats:sec><jats:title>Backround<\/jats:title><jats:p>The interventional treatment of functional mitral regurgitation (FMR) with the MitraClip<jats:sup>\u00ae<\/jats:sup> system could improve the clinical and hemodynamic outcome in patients with severely impaired left ventricular function.<\/jats:p><\/jats:sec><jats:sec><jats:title>Materials and methods<\/jats:title><jats:p>Between 2011 and 2016, a total of 147 patients with FMR were treated with MitraClip<jats:sup>\u00ae<\/jats:sup> at our institution. The cohort was divided into two groups: LVEF\u2009\u2265\u200920% (<jats:italic>N<\/jats:italic>\u2009=\u2009126) and &lt;20% (<jats:italic>N<\/jats:italic>\u2009=\u200921). Follow\u2010up assessments included exercise capacity, 6\u2010min walk test, probrain natriuretic peptide\u2010measurement (ProBNP), echocardiography and right heart catheterization. Only three patients with an LVEF\u2009\u2265\u200920% and one patient with an LVEF\u2009&lt;\u200920% were lost for follow\u2010up.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>In the vast majority of patients, a reduction from severe to mild MR was demonstrated with no difference between both groups (<jats:italic>P<\/jats:italic>\u2009=\u20090.422). At follow\u2010up, both subgroups experienced similar improvements in exercise capacity and hemodynamics. Patients with an LVEF\u2009&lt;\u200920% were on average 5.8 years younger, while mortality rates were comparable in both groups (<jats:italic>P<\/jats:italic>\u2009=\u20090.760).<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusion<\/jats:title><jats:p>By careful selection, even patients in the end stage of advanced LV dysfunction as the result of the underlying myogenic problem and the additional harmful effects of the high volume loading due to the FMR can exhibit significant clinical and hemodynamic improvement after MitraClip<jats:sup>\u00a9<\/jats:sup> therapy.<\/jats:p><\/jats:sec>","DOI":"10.1002\/ccd.27159","type":"journal-article","created":{"date-parts":[[2017,6,1]],"date-time":"2017-06-01T07:42:46Z","timestamp":1496302966000},"page":"1038-1045","source":"Crossref","is-referenced-by-count":13,"title":["Left ventricular ejection fraction of\u2009&lt;\u200920%: Too bad for MitraClip<sup>\u00a9<\/sup>?"],"prefix":"10.1002","volume":"90","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-9549-3503","authenticated-orcid":false,"given":"Sebastian","family":"Barth","sequence":"first","affiliation":[{"name":"Department of Cardiology Cardiovascular Center, Bad Neustadt  Germany"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Martina B.","family":"Hautmann","sequence":"additional","affiliation":[{"name":"Department of Cardiology Cardiovascular Center, Bad Neustadt  Germany"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sebastian","family":"Kerber","sequence":"additional","affiliation":[{"name":"Department of Cardiology Cardiovascular Center, Bad Neustadt  Germany"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Frank","family":"Gietzen","sequence":"additional","affiliation":[{"name":"Department of Cardiology Cardiovascular Center, Bad Neustadt  Germany"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wilko","family":"Reents","sequence":"additional","affiliation":[{"name":"Department of Cardiac surgery Cardiovascular Center, Bad Neustadt  Germany"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michael","family":"Zacher","sequence":"additional","affiliation":[{"name":"Department of Cardiac surgery Cardiovascular Center, Bad Neustadt  Germany"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Philipp","family":"Halbfass","sequence":"additional","affiliation":[{"name":"Department of Cardiology Cardiovascular Center, Bad Neustadt  Germany"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Daniel P.","family":"Griese","sequence":"additional","affiliation":[{"name":"Department of Cardiology SANA\u2010clinic Hameln\u2010Pyrmont Hameln Germany"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bernhard","family":"Schieffer","sequence":"additional","affiliation":[{"name":"Department of Cardiology University of Marburg Marburg Germany"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5808-5842","authenticated-orcid":false,"given":"Karsten","family":"Hamm","sequence":"additional","affiliation":[{"name":"Department of Cardiology Cardiovascular Center, Bad Neustadt  Germany"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2017,6]]},"reference":[{"key":"e_1_2_7_2_1","doi-asserted-by":"publisher","DOI":"10.1093\/eurheartj\/ehs109"},{"key":"e_1_2_7_3_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1009355"},{"key":"e_1_2_7_4_1","doi-asserted-by":"publisher","DOI":"10.1093\/eurjhf\/hfr029"},{"key":"e_1_2_7_5_1","doi-asserted-by":"publisher","DOI":"10.1093\/eurheartj\/ehm001"},{"key":"e_1_2_7_6_1","first-page":"475","article-title":"Hemodynamic improvement at three months after MitraClip\u00ae treatment in end\u2010stage heart failure patients with functional mitral regurgitation","volume":"25","author":"Barth S","year":"2016","journal-title":"J Heart Valve Dis"},{"key":"e_1_2_7_7_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.amjcard.2016.06.036"},{"key":"e_1_2_7_8_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jacc.2013.08.723"},{"key":"e_1_2_7_9_1","doi-asserted-by":"publisher","DOI":"10.1093\/europace\/eur047"},{"key":"e_1_2_7_10_1","doi-asserted-by":"publisher","DOI":"10.1093\/eurheartj\/ehw128"},{"key":"e_1_2_7_11_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jacc.2013.02.094"},{"key":"e_1_2_7_12_1","doi-asserted-by":"publisher","DOI":"10.1093\/eurjhf\/hfr141"},{"key":"e_1_2_7_13_1","doi-asserted-by":"publisher","DOI":"10.1093\/eurheartj\/ehq050"},{"key":"e_1_2_7_14_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jacc.2014.06.1166"},{"key":"e_1_2_7_15_1","article-title":"Clinical efficiacy and safety of MitraClip TM implantation in patients with low ejection fraction: data from the German mitral valve registry","volume":"101","author":"Bekeredjian R","year":"2012","journal-title":"Clin Res Cardiol"},{"key":"e_1_2_7_16_1","doi-asserted-by":"publisher","DOI":"10.1093\/eurheartj\/ehv627"},{"key":"e_1_2_7_17_1","unstructured":"A Clinical Evaluation of the Safety and Effectiveness of the MitraClip\u00aeSystem for the Treatment of Functional Mitral Regurgitation in Symptomatic Heart Failure Subjects.ClinicalTrials.govIdentifier: NCT01626079. Retrieved from:http:\/\/www.limesurvey.org"},{"key":"e_1_2_7_18_1","unstructured":"Observational Study of Heart Failure Patients With Clinically Significant Functional Mitral Regurgitation \u2013 Follow\u2010up of the former Participants in the RESHAPE\u2010HF Trial (Abbott Vascular);ClinicalTrials.govIdentifier: NCT02444286. Retrieved from:http:\/\/www.clinicaltrials.gov"}],"container-title":["Catheterization and Cardiovascular Interventions"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1002%2Fccd.27159","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1002\/ccd.27159","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,9,26]],"date-time":"2023-09-26T12:33:16Z","timestamp":1695731596000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1002\/ccd.27159"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,6]]},"references-count":17,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2017,11,15]]}},"alternative-id":["10.1002\/ccd.27159"],"URL":"https:\/\/doi.org\/10.1002\/ccd.27159","archive":["Portico"],"relation":{},"ISSN":["1522-1946","1522-726X"],"issn-type":[{"value":"1522-1946","type":"print"},{"value":"1522-726X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,6]]}}}